TCG Labs
Venture capitalSan Francisco · 2 people tracked
Also known as TCG LABS MANAGEMENT, LP
Investment thesis
TCG Labs Soleil pursues a venture-biotech model built in collaboration with The Column Group, combining dedicated capital with an evergreen, scientist-led R&D hub. It forms independent portfolio companies each focused on a single therapeutic asset, guiding them from ideation through clinical proof of concept and positioning them for strategic partnerships. The firm deploys capital, scientific leadership, and operational infrastructure to advance both internally originated and externally acquired programs, as illustrated by its acquisition and clinical development of a KLK2-directed T-cell engager for metastatic prostate cancer through its portfolio company Juri Biosciences.
Source: firm website, verified Aug 25, 2026.
Team · 2 people
from the firm's website
What they invest in
from 1 of 2 portfolio companiesBiotech ×1Healthtech ×1
HQs:China×1
Investments · 2 tracked
founders shown can be your intro pathEpimAb Biotherapeutics develops bispecific antibody drugs for immuno-oncology and other high-need therapeutic areas using its proprietary FIT-Ig platform, with a pipeline of clinical programs (EMB-01, EMB-06, EMB-07) and preclinical candidates.
BiotechHealthtechShanghai, CN
Co-investorsDecheng CapitalShangBay Capital LLC3E Bioventures CapitalSherpa Healthcare Partners
TCG Labs Soleil portfolio company developing a KLK2-directed T-cell engager for metastatic prostate cancer under a worldwide license from EpimAb.
Frequently asked questions
- What sectors does TCG Labs focus on?
- TCG Labs focuses on Biotech, Healthtech, Medical Devices.
- Where is TCG Labs located?
- TCG Labs is headquartered in San Francisco, US.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.